---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-003490"
form_type: "8-K"
ticker: "AEMD"
cik: "0000882291"
company_name: "AETHLON MEDICAL INC"
filed_at: "2025-05-13T23:59:59+00:00"
generated_at: "2026-05-21T19:48:32.932681+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Aethlon Medical stockholders approve reverse stock split authorization and warrant issuance at special meeting

## Summary
- Stockholders approved reverse split at ratio 1:5 to 1:12, board to determine timing by May 13, 2026.
- Approval granted for issuance of shares upon exercise of Inducement Warrants and Reset of Exercise Price provision.
- All three proposals passed; adjournment proposal approved but not needed as quorum and votes sufficient.
- Approximately 38.78% of outstanding shares (6.2M of 16.1M) represented at meeting.

## SEC filing metadata
- accession: 0001683168-25-003490
- form_type: 8-K
- ticker: AEMD
- cik: 0000882291
- company_name: AETHLON MEDICAL INC
- filed_at: 2025-05-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/882291/000168316825003490/0001683168-25-003490-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/882291/000168316825003490/aemd_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-003490
- JSON: https://secwatch.observer/filing/0001683168-25-003490.json
- Plain text: https://secwatch.observer/filing/0001683168-25-003490.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.